Iterum Therapeutics Announces Pricing of $17.5 Million Upsized Public Offering –...

Iterum Therapeutics Announces Pricing of $17.5 Million Upsized Public Offering - Oct 23, 2020

Zydus receives approval from COFEPRIS to conduct clinical trials in Mexico...

Zydus receives approval from COFEPRIS to conduct clinical trials in Mexico with Pegylated Interferon alpha-2b to treat novel Coronavirus - FirstWord Pharma

ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical...

ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical Trial of EPI-7386 for Metastatic Castration-Resistant Prostrate Cancer

BOLD-100 Demonstrates Nanomolar Range Inhibition of Live COVID-19 In Vitro

BOLD-100 Demonstrates Nanomolar Range Inhibition of Live COVID-19 In Vitro

BOLD-100 Demonstrates Nanomolar Range Inhibition of Live COVID-19 In Vitro

BOLD-100 Demonstrates Nanomolar Range Inhibition of Live COVID-19 In Vitro
- Advertisement -

LATEST NEWS

MUST READ